Skip to content

Tilray Brands, Inc. TLRY Restricted Cash

Restricted Cash at other companies

Canopy Growth Corporation logo
Canopy Growth CorporationCGC
$5.05M-21.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$57K
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$1.73M+308%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$13M-43.5%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$259K-17.8%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$4.17M-36.6%

Other financials

Income statement

See full
Revenue$206.7M+11.3%
Gross profit$55.0M+5.7%
Operating income-$26.4M+96.5%
Net income-$26.6M+96.6%
EPS (diluted)-$0.24+97.2%

Balance sheet

See full
Cash & equivalents$204.6M+2.3%
Total debt$211.4M-6.9%
Total equity$1.6B-42.9%
Total assets$2.1B-39.0%

Cash flow

See full
Operating cash flow-$21.9M-281%
CapEx$6.3M-34.8%
Free cash flow-$19.1M

Valuation

See full
Market cap$538.85M+47.3%
Enterprise value$545.59M+46.8%
P/S0.6×+0.2×

Profitability

See full
Gross margin30.9%+2.9pp
Operating margin-103.5%-198pp
Net margin-156.1%+89.5pp
FCF margin-15.5%

Returns & leverage

See full
Return on equity-62.5%-1,636pp
Debt / equity0.1×+0.1×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Tilray Brands, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue.

The official record: Tilray Brands, Inc.’s 10-Q, filed April 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tilray Brands, Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tilray Brands, Inc.'s restricted cash?
Tilray Brands, Inc. (TLRY) reported restricted cash of $44.89M in Q4 2025.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.